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Background: Most surgeons routinely place intraperitoneal drains at the time of pancreatic resection but
this practice has recently been challenged.
Objective: Evaluate the outcome when pancreatic resection is performed without operatively placed
intraperitoneal drains.
Methods: In all, 226 consecutive patients underwent pancreatic resection. In 179 patients drains were
routinely placed at the time of surgery and in 47 no drains were placed. Outcomes for these two cohorts
were recorded in a prospective database and compared using the c2- /Fisher's exact test for categorical
variables, and Wilcoxon's test for continuous variables.
Results: Demographic, surgical and pathological details were similar between the two cohorts. Elimi-
nation of routine intraperitoneal drainage did not increase the frequency or severity of serious complica-
tions. However, when all grades of complications were considered, the number of patients that
experienced any complication (65% vs. 47%, P = 0.020) and the median complication severity grade (1
vs. 0, P = 0.027) were increased in the group that had drains placed at the time of surgery. Eliminating
intra-operative drains was associated with decreased delayed gastric emptying (24% vs. 9%, P = 0.020)
and a trend towards decreased wound infection (12% vs. 2%, P = 0.054). The readmission rate (9% vs.
17% P = 0.007) and number of patients requiring post-operative percutaneous drains (2% vs. 11%, P =
0.001) was higher in patients who did not have operatively placed drains but there was no difference in
the re-operation rate (4% vs. 0%, P = 0.210).
Conclusion: Abandoning the practice of routine intraperitoneal drainage after pancreatic resection may
not increase the incidence or severity of severe post-operative complications.
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Introduction
For decades, routine placement of intraperitoneal drains after
pancreatic resection and anastomosis has been considered man-
datory.Although the use of drains has proven to be unnecessary or
even deleterious in other operations such as a splenectomy,
gastrectomy and colorectal resection, many surgeons fear that
abandoning routine intraperitoneal drainage after a pancreati-
coduodenectomy would not be safe. The purpose of these drains
is to evacuate blood, bile, pancreatic juice or chyle, that may accu-
mulate after surgery and to serve as an early warning sign of
anastomotic leak and associated haemorrhage.Although failure of
the enteric or biliary anastomosis is relatively uncommon after a
pancreaticoduodenectomy, a post-operative pancreatic fistula
remains a significant problem in about 10% of patients.1,2 A pan-
creatic fistula is thought to contribute to the most morbid com-
plications of the operation particularly when combined with
biliary leakage which activates pancreatic enzymes and can lead to
erosion of retroperitoneal vessels and haemorrhage, intra-
abdominal abscess, sepsis, multi-system organ failure and death.
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The majority of patients do not develop a post-operative pan-
creatic fistula and experience with drains in other operations sug-
gests that unnecessary drains may cause complications. Drains
can serve as a portal of entry for bacteria and change a benign
post-operative fluid collection into an abscess. Drains can cause
trauma from suction and can certainly erode into anastomoses
and cause leaks.
Some surgeons have abandoned the routine use of drains
whereas others have taken a compromise position by removing
drains early in the post-operative period based on drain volume
and amylase content.3,4 However, the early dynamic post-operative
changes in drain volume and amylase concentration are not
clearly correlated with the later development of a clinically signifi-
cant post-operative pancreatic fistula making this approach
problematic.5,6
In recent years, the ability to place drains post-operatively using
ultrasound or computed tomography has provided some measure
of increased safety for pancreas resection without the use of
routine intraperitoneal drainage. If patients develop signs or
symptoms of a clinically significant post-operative pancreatic
fistula or another fluid collection, a drain can almost always
be safely placed and a return to the operating room is often
unnecessary.7
Methods
In all, 226 consecutive patients underwent a pancreatic resection
by a single surgeon (W.E.F.). From 2004 to 2009 (Cohort 1, n =
179), drains were routinely placed at the time of surgery. For the
Whipple procedure, two closed-suction drains were placed near
the biliary and pancreatic anastomoses. For distal pancreatecto-
mies, one closed-suction drain was placed near the pancreatic
transection margin. Drains were removed when output decreased
to <20 ml/day and amylase concentration was <360 IU/ml (3¥ the
upper limit of the normal serum value). In 2009, a decision was
made to perform a pancreatic resection without routine intrap-
eritoneal drainage for all patients requiring resection. In the
second cohort of consecutive patients (2009 to 2010, n = 47) no
drains were placed at the time of surgery. No patients were
excluded from the study.
Demographic information was obtained from the medical
records.A stated past medical history of or presence in themedical
record of a history of hypertension, chronic obstructive pulmo-
nary disease, diabetes, coronary artery disease, chronic pancreati-
tis or renal insufficiency was recorded. Obesity was defined as a
bodymass index (BMI) greater than or equal to 30 kg/m2. Tobacco
use was recorded as never, ever or current smoker. The American
Society of Anesthesiologists (ASA) score was obtained from the
anaesthesia record. Operative time was also obtained from the
anaesthesia record and defined as the time from incision to appli-
cation of the final wound dressing. Estimated intra-operative
blood loss (EBL) was obtained from the anaesthesia record, not
from the surgeon’s operative report. The surgeon graded the pan-
creatic texture as soft/normal or hard in the operative note. The
surgeon measured the pancreatic duct with a probe and recorded
the size of the duct in the operative note (3 mm was considered
normal). All specimens were submitted to pathological analysis,
and the diagnosis and staging was recorded.
Operative mortality was defined as any death within 30 days of
surgery. All complications within 30 days of the date of surgery
were recorded using specific and standardized definitions. Com-
plications were defined and graded in severity using the Common
Terminology Criteria for Adverse Events CTCAE (v4.0) (Grade
1–5) unless otherwise stated below. For grading schemes with A,
B, C rather than 1–5, severity scores were converted to 1–3 to
calculate median complication severity scores.
Anastomotic failure
A pancreatic fistula was defined and graded using the three-tiered
definition proposed by the International Study Group on Pancre-
atic Fistula (ISGPF).8 For patients with drains, the maximum
drain amylase concentration (highest concentration in any drain)
was recorded and used for the analysis. Biliary leak was defined as
drainage of any volume of fluid clinically consistent with bile (or
with a bilirubin concentration greater than the serum value) from
operatively or percutaneously placed drains or the wound.
Percutaneous abdominal drainage
Fluid drained from the abdomen with a positive Gram stain or
culture was considered an intra-abdominal abscess. Fluid drained
from the abdomen with an amylase concentration >360 IU/ml
was considered a pancreatic fistula. Two complications were
logged if the fluid met both the criteria for an abscess and fistula.
The need for percutaneous abdominal drainage (placement of an
intra-abdominal drain using any image-guided technique such as
CT or ultrasound) or even reoperation was not counted as a
separate additional complication but was used to grade the sever-
ity of the complication that was the indication for the procedure
(pancreatic fistula, abdominal abscess, etc.).
Delayed gastric emptying (DGE)
Delayed gastric emptying was defined and graded using the
schema proposed by the International Study Group of Pancreatic
Surgery (ISGPS).9 Grade A delayed gastric emptying (DGE) was
considered present in patients who required a nasogastric tube
(NGT) between postoperative day (POD) 4 and 7 (including rein-
sertion for nausea or vomiting after initial removal), or those who
failed to tolerate a solid diet by POD 7, but did tolerate a solid diet
before POD 14. Grade B DGE was considered present in patients
who required an NGT from POD 8–14 (including reinsertion for
nausea or vomiting after initial removal) or in patients who could
not tolerate a solid oral intake by POD 14, but were able to resume
a solid oral diet before POD 21. Grade C DGE was considered
present in patients who required an NGT after POD 14 (including
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reinsertion for nausea or vomiting after initial removal), or in
patients who were not able to maintain a solid oral intake by POD
21.10
Infectious complications and organ failure
Fever was defined as any recorded temperature greater than or
equal to 100.4°F (38.0°C). Wound infection was defined as spon-
taneous or surgical drainage from the wound with a positive Gram
stain or culture. As stated above, an intra-abdominal abscess was
defined as fluid drained from the abdomen with a positive Gram
stain or culture. Pneumonia was defined as a positive sputum
culture associated with an infiltrate on radiological imaging
requiring treatment with antibiotics. Clostridium dificile colitis
was defined as diarrhoea associated with a positive stool culture
for the organism. A urinary tract infection (UTI) was defined as a
urine culture with103 colony forming units per millilitre. Acute
Respiratory Distress Syndrome (ARDS) was defined as the pres-
ence of a PaO2/FiO2 < 200 mmHg in the presence of bilateral
alveolar infiltrates on chest X-ray. Renal failure was defined as the
need for dialysis of any duration in patients who did not require
dialysis pre-operatively. Urinary retention was defined as the need
to reinsert a Foley catheter at any time during the index admission
owing to an inability to void and a distended bladder.
Cardiovascular complications
Arrhythmia was defined as any new (not present pre-operatively)
cardiac rhythm other than sinus requiring any medical interven-
tion or transfer to a monitored bed. A myocardial infarction (MI)
was defined as two or more of the following: chest pain, electro-
cardiograph changes and/or cardiac enzyme elevation and a fall
consistent with MI. A post-operative haemorrhage was defined as
a need to return to the operating room or post-operative radio-
logical intervention for haemorrhage, or post-operative gas-
trointestinal bleeding documented by endoscopy. Deep venous
thrombosis (DVT) was defined as a new thrombosis of the super-
ficial femoral, femoral, iliac, brachial, or subclavian veins, internal
jugular, or the inferior or superior vena cava. A DVT was diag-
nosed with extremity ultrasound, computed tomography (CT) or
other imaging. A pulmonary embolus (PE) was defined as a new
thrombosis of a pulmonary artery and was diagnosed with CT or
another imaging modality. Portal or superior mesenteric venous
thrombosis was counted as a DVT and was defined as newly
diagnosed thrombosis of the PV or SMV documented by any
imaging modality such as a CT that was not present before
surgery.
Length of stay
Length-of-hospital (LOS) stay was calculated from the day of
surgery through and including the day of discharge during the
index admission. Return to the intensive care unit (ICU) after
discharge to the regular hospital ward was not considered a com-
plication but was used to grade the severity of the reason for
return to the ICU (arrhythmia, etc.). Readmission was defined as
an admission to any hospital for 24 h for any reason within 30
days after surgery. Readmission was not considered as an indepen-
dent additional complication but was used to grade the severity of
the complication that was the reason for readmission. The length
of readmission was calculated using the day of readmission to and
including the day of discharge.
Data analysis
Outcomes for the two cohorts were recorded in a prospective
database and reviewed retrospectively. Groups were compared
using a c2-/Fisher’s exact test for categorical variables, and Wil-
coxon’s test for continuous variables (median, interquartile
range). Data were entered into the Institutional Review Board-
approved prospective database in real time by a trained data
analyst under the supervision of the surgeon. All data were backed
up by source documents and the accuracy of the data entered into
the electronic database was periodically reviewed.
Results
Two consecutive cohorts of patients (226 patients total) undergo-
ing pancreatic resection fromMay 11 2004 to August 14 2010 were
compared. In the first cohort (179 patients), drains were routinely
placed at the time of surgery and in the second cohort (47
patients) no drains were placed at the time of surgery. The two
cohorts were very similar in all respects. Patients who had a pan-
creaticoduodenectomy or a distal pancreatectomy were included
in the present study and there was no difference between the two
cohorts in the type of resection. There were also no differences in
age, gender, race or ethnicity between the two cohorts (Table 1).
There was a higher incidence of hypertension and chronic
obstructive pulmonary disease in the group without routine intra-
peritoneal drainage. There were no clinically significant differ-
ences in pre-operative labs between the two cohorts (Table 2).
There were no differences between the two cohorts in the size of
the pancreatic duct or the texture of the pancreas (Table 3).
However, there was some evolution of surgical technique over
time from the first (2004 to 2009) to second (2009 to 2010)
cohort. The surgeon elected to use an internal pancreatic duct
stent for the pancreaticojejunostomy more frequently and there
was a decrease in estimated blood loss and transfusions. These
changes were not likely related in any way to the use of intra-
operative drains but represent changes and perhaps improvement
in surgical technique over time. There were no differences
between the two cohorts in the indication for resection (Table 4).
Mortality was low in this series and there was no difference
between the two groups (Table 5). One patient died of hepatic
failure during the index admission and one of urosepsis after
discharge. No patients had a prolonged (>30-day) hospital stay so
the in-hospital mortality is the same as the 30-day mortality. The
frequency and severity of severe complications experienced was
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not increased by eliminating routine intra-operative drainage.
The number of complications experienced per patient was similar
in each cohort. The incidence of more severe complications
(Grade II or III) was also similar between the two cohorts. Among
patients that had a complication, the median complication sever-
ity grade was the same in each cohort (2 vs. 2, P = 0.677).However,
when all patients, those with and those without complications
were considered, there was a statistically significant increase in the
number of patients who experienced any complication (65% vs.
47%, P < 0.020) in the group that had drains and the median
complication severity grade was higher in the group that had
drains (1 vs. 0, P < 0.027).
The spectrum of complications was slightly different in the two
cohorts. (Table 5). Of course, elimination of routine intra-
operative drains completely eliminated the category of a Grade A
post-operative pancreatic fistula because all patients in this cohort
Table 1 Demographics
Cohort 1 Cohort 2 P-value
Drain (n = 179) No drain (n = 47)
Age (median, interquartile range) 63 (53–72) 59 (51–70) 0.341***
Gender 0.698**
Male 78 (44%) 19 (40%)
Race 0.132*
White 162 (90%) 37 (79%)
Black 12 (6%) 7 (15%)
Asian 1 (1%) 1 (2%)
Pacific Islander 2 (1%) 2 (4%)
Others 2 (1%) 0 (90%)
Ethnicity 0.749*
Hispanic 12 (7%) 4 (9%)
*Fisher's exact test, **c2-test, ***Wilcoxon's rank sum test.
Table 2 Comorbid conditions and pre-operative labs
Cohort 1 Cohort 2 P-value
Drain (n = 179) No drain (n = 47)
Hypertension 46 (26%) 26 (55%) 0.0001**
Chronic pancreatitis 14 (8%) 6 (13%) 0.384*
Coronary artery disease 18 (10%) 8 (17%) 0.183**
History of myocardial infarction 4 (2%) 2 (4%) 0.607*
Chronic obstructive pulmonary disease 21 (12%) 11 (23%) 0.041**
Obesity (body mass index >30) 41 (23%) 17 (36%) 0.067**
Tobacco use 0.630**
Current 40 (23%) 8 (18%)
Ever 63 (36%) 15 (33%)
Never 73 (41%) 22 (49%)
ASA 0.698*
1 2 (1%) 1 (2%)
2 66 (37%) 15 (37%)
3 99 (55%) 29 (62%)
4 12 (7%) 2 (4%)
Albumin (g/dl) 4.1 (3.8–4.4) 4.2 (3.7–4.4) 0.682***
Creatinine (mg/dl) 0.9 (0.8–1.1) 0.9 (0.7–1.1) 0.266***
Total bilirubin (mg/dl) 0.2 (0.1–0.7) 0.6 (0.4–1.0) <0.0001***
Haemoglobin (g/dl) 12.8 (11.4–13.9) 13.5 (12.5–14.7) 0.012***
*Fisher's exact test, **c2-test, ***Wilcoxon's rank sum test.
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who required image-guided percutaneous drainage of intra-
abdominal fluid with an elevated amylase concentration were
defined as having at least Grade B pancreatic fistulae (not A).
However, eliminating intra-operative drains did not change the
incidence or severity of clinically significant (Grade B or C) pan-
creatic fistula (Table 5). Of course all five patients (11%) who
developed a pancreatic fistula in the cohort that did not have an
operatively placed drain required percutaneous drainage and two
of these patients (4%) also met the criteria for an abdominal
abscess.
Among the patients without drains placed at the initial opera-
tion, none required a return to the operating room for a pancre-
atic fistula and/or abscess. In the first cohort, three patients (2%)
had a pancreatic leak or abscess that was not controlled with the
operatively placed drain and required a post-operative percutane-
ous drain. In addition, eight patients (4%) in the first cohort
required reoperation. Among the group without drains placed at
the time of pancreas resection none required a return to the oper-
ating room. Elimination of a routine intra-operative drain place-
ment also seemed to be associated with a trend towards a decrease
in the rate of wound infection (12% vs. 2%, P = 0.054).
Elimination of a routine intra-operative drain placement was
associated with a statistically significant decrease in the length of
hospital stay but the median was 7 days for each cohort. However,
there was a significant increase in the readmission rate (9% vs.
17% P = 0.007). The five patients who did not have drains placed
at the time of resection who developed post-operative pancreatic
fistulae were readmitted for percutaneous drain placement and
three additional patients were admitted simply for observation.
Most patients who required post-operative percutaneous drainage
were readmitted about 19 days after their pancreas resection. As
experienced is gained, it may be possible to manage some of these
patients without hospital readmission.Most of these patients were
discharged rapidly after percutaneous drain placement so there
was not much difference in length of stay even when the readmis-
sion days were added to the index admission.
An additional analysis was performed on the subset of patients
that we defined as having a high risk for a pancreatic leak [pres-
ence of soft pancreas and/or small (<3 mm) pancreatic duct]. In
all, 33% of the patients in the drained cohort, and 47% of the
patients in the no drain cohort met these criteria. When consid-
ering just this subset, there was no statistically significant differ-
ence in the frequency or severity of complications experienced by
the two cohorts. The clinically significant (Grade B/C) pancreatic
leak rate was 15% vs. 14% (NS).
Discussion
As a result of the high incidence of post-operative pancreatic
fistulae and other sometimes related complications such as an
intra-abdominal abscess, biliary leak, enteric leak or even haem-
orrhage, it has been a surgical dogma for decades that drains
Table 3 Intra-operative data
Cohort 1 Cohort 2 P-value
Drain (n = 179) No drain (n = 47)
Procedure 0.524**
Pancreaticoduodenectomy 123 (69%) 30 (64%)
Distal pancreatectomy 56 (31%) 17 (36%)
Pancreatic texture (Soft) 87 (56%) 25 (53%) 0.606**
Pancreatic duct (normal, 3 mm) 83 (52%) 27 (57%) 0.082**
Pancreatic duct stent 34 (28%) 27 (57%) <0.0001**
Operating time (min) 401 (310–490) 400 (314–458) 0.396***
Estimated blood loss (ml) 400 (200–700) 250 (150–500) 0.006***
Transfusion 34 (19%) 3 (6%) 0.038**
*Fisher's exact test, **c2-test, ***Wilcoxon's rank sum test.
Note: the pancreatic duct stent is for Whipple only.
Table 4 Pathology
Cohort 1 Cohort 2 P-value*
Drain (n = 179) No Drain (n = 47)
Cancer 91 (51%) 22 (47%) 0.202
Cystic Neoplasm 36 (20%) 16 (34%)
Pancreatitis 30 (17%) 5 (11%)
Other 22 (12%) 4 (9%)
*c2-test.
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Table 5 30-day outcome data
Overall morbidity and mortality Cohort 1
(n = 179)
Cohort 2
(n = 47)
P-value
30-day mortality 1 (1%) 1 (1%) 0.373*
Severity of complications
Patients with any complication grade III 38 (21%) 7 (15%) 0.333**
Patients with any complication grade II 52 (29%) 12 (26%) 0.634**
Patients with any complication grade I 117 (65%) 22 (47%) 0.020**
Median complication severity grade (median, quintiles) for patients with complications 2 (1–4) 2 (1–4) 0.677
Median complication severity grade (median, quintiles) for all patients 1 (0–3) 0 (0–2) 0.027***
Number of complications (any grade) 0.351*
Patients with one complication 54 (30%) 13 (28%)
Patients with two complications 35 (20%) 5 (11%)
Patients with three complications 19 (11%) 3 (6%)
Patients with four complications 4 (2%) 1 (2%)
Patients with five complications 4 (2%) 0 (0%)
Patients with > five complications 1 (1%) 0 (0%)
Specific complications Cohort 1 Cohort 2 P-value
Pancreatic fistula ( No vs. A/B/C) 79 (44%) 5 (11%) <0.0001**
Pancreatic fistula (Grade A) 58 (32%) 0 (0%) <0.0001*
Pancreatic fistula (Grade B) 17 (10%) 5 (11%)
Pancreatic fistula (Grade C) 4 (2%) 0 (0%)
Wound Infection 22 (12%) 1 (2%) 0.054*
Wound Dehiscence 1 (1%) 0 (0%) 1.000*
Intra-abdominal abscess 10 (6%) 2 (4%) 1.000*
Delayed gastric emptying (No vs. A/B/C) 43 (24%) 4 (9%) 0.020**
Grade A 32 (18%) 4 (9%) 0.143*
Grade B 8 (4%) 0 (0%)
Grade C 3 (2%) 0 (0%)
Pneumonia 3 (2%) 0 (0%) 1.000*
Biliary leak 1 (1%) 0 (0%) 1.000*
Encephalopathy 1 (1%) 1 (2%) 0.373*
New arrhythmia 4 (2%) 0 (0%) 0.583*
Myocardial infarction 0 (0%) 1 (2%) 0.208*
Urinary retention 0 (0%) 1 (2%) 0.209*
Urinary tract infection 6 (3%) 1 (2%) 1.000*
Deep venous thrombosis 2 (1%) 2 (4%) 0.192*
Organ failure 1 (1%) 0 (0%) 1.000
Haemorrhage 3 (2%) 0 (0%) 1.000*
Acute respiratory distress syndrome 2 (1%) 0 (0%) 1.000*
Pulmonary embolus 2 (1%) 1 (2%) 0.507*
Fever 41 (23%) 16 (34%) 0.118**
Post-operative procedures Cohort 1 Cohort 2 P-value
Post-operative percutaneous drain 4 (2%) 5 (11%) 0.001*
Re-operation 8 (4%) 0 (0%) 0.210*
Length of stay (index admission) 7 (7–10) 7 (6–8) 0.004***
Readmission 17 (9%) 8 (17%) 0.007*
Total length of stay (index + readmission) 7 (7–11) 7 (6–9) 0.016***
*Fisher's exact test, **c2-test, ***Wilcoxon's rank sum test.
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should be placed at the time of all pancreatic resections. In other
operations, the use of drains has steadily decreased as data have
been generated to demonstrate a lack of benefit and even potential
harm from their use. However, surgeons have been reluctant to
eliminate the routine use of intra-peritoneal drains after pancre-
atic resection.
In this prospective cohort study, 179 consecutive patients who
had a pancreatic resection with placement of intra-peritoneal
drains were compared with a subsequent cohort of 47 consecutive
patients who had a pancreatic resection without drainage. We
found no increase in mortality when drains were eliminated and
the frequency or severity of severe complications experienced was
not increased. Eliminating the practice of routine intra-peritoneal
drainage altered the spectrum of complications experienced with
a decrease in the incidence of delayed gastric emptying and a trend
towards a decrease in wound infection and an increase in the need
for readmission and post-operative percutaneous drainage.
We did not conduct a formal cost analysis as part of the present
study. The cost of drains themselves is insignificant. However, the
increase in the readmission rate and need for subsequent image-
guided percutaneous drainage with the elimination of routine
intra-operative drainage would be expected to increase the cost of
care. It should be noted that the investigators were conservative
and took an aggressive approach towards ensuring patient safety
in the present study. Patients without operatively placed drains
were followed very closely and all complaints were thoroughly
investigated. As experience and confidence is gained with pancre-
atic resection without drainage, the need for post-operative inter-
ventions such as imaging and readmission may be decreased.
Experience in other areas of surgery where drains have been
proven to be unnecessary or even harmful makes elimination of
routine drainage after a pancreatic resection seem logical
However, the fear of devastating complications secondary to a
pancreatic leak without drainage keeps most surgeons from aban-
doning the practice of routine drainage after a pancreatic resec-
tion. Some surgeons have adopted a practice of early drain
removal hoping to eliminate the potential harm of drains but still
enjoy the security of an ‘early warning system’ for anastomotic
complications. Bassi examined this question in patients deemed to
have a low risk of a pancreatic fistula (drain fluid amylase con-
centration5000 U/l on POD 1).4 A total of 114 eligible patients
were randomized to early (POD 3) or late drain removal. Early
drain removal was associated with a decreased rate of a pancreatic
fistula and abdominal complications. The authors concluded
that, in patients at low risk of a pancreatic fistula, intra-
abdominal drains can be safely removed early and this may
decrease complications.
However, there are numerous problems with this approach. The
ideal time to remove the drain is controversial. Many surgeons
assume that increased drainage with high amylase content in the
first few days after surgery signals a developing clinically signifi-
cant post-operative pancreatic fistula. Our group reported a series
of 177 pancreatic resections in which the drain output and
amylase concentration was recorded daily until the drains were
removed.6 We found that this drain data on any particular POD
was not sensitive or specific enough to be used as an accurate
clinical predictor of subsequent post-operative pancreatic fistula.
Some clinically significant leaks may begin late in the post-
operative course and this would be after early drain removal.
Without the highest level of evidence it will be difficult to
change the opinion of most pancreatic surgeons regarding the
routine use of intra-abdominal drains after a pancreatic resection.
Some surgeons may be more apt to adopt this approach in
patients with chronic pancreatitis who have a dilated pancreatic
duct and hard pancreatic parenchyma but more reluctant to
abandon routine drainage when the pancreas is soft and the pan-
creatic duct is small. The present study included both a pancre-
aticoduodenectomy and a distal pancreatectomy and a diverse
mixture of patients with pancreatic tumours, cystic lesions and
chronic pancreatitis. Among the subset of patients who had a
pancreatic texture that was deemed soft (normal) and a small
pancreatic duct (<3 mm) there was no statistically significant dif-
ference in any outcome measure. The present data suggest that it
may be safe to eliminate routine drainage even in this subset of
patients; however, a randomized prospective trial is required to
definitively test this hypothesis.
Data in the literature on pancreatic resection without drainage
are currently limited. Jeekel provided a retrospective case series of
22 patients who underwent a pancreaticoduodenectomy without
drainage.11 Three patients developed an intra-abdominal abscess
and all were managed with percutaneous postoperative drainage.
Heslin retrospectively reviewed a series of 89 patients, 51 (57%)
with and 38 (43%) without routine intra-peritoneal drainage.12
There was no statistical difference in the rate or type of compli-
cations or LOS between patients who had a drain placed and those
who did not. Perhaps the best level of evidence available is from a
single-institution randomized prospective trial in which 179
patients undergoing either a pancreaticoduodenectomy or a distal
pancreatectomy for pancreatic tumours were randomized to
routine intra-abdominal drainage (89 patients) or no drains (90
patients).10 There was no significant difference in the number or
type of complications between the two groups and the authors
concluded that closed-suction drainage should not be considered
mandatory after pancreatic resection.
The present study adds to the existing small body of literature
suggesting that routine intra-peritoneal drainage after a pancre-
atic resection may not be necessary. Careful analysis of the two
cohorts revealed that they were very similar in terms of demo-
graphic, surgical and pathological details that may affect the inci-
dence and severity of complications. However, one potential
weakness of the present cohort study is that the clinical practice of
surgery evolved during enrolment. There is a possibility that any
changes over time such as decreased blood loss and transfusion
rate and overall efforts to decrease LOS could have confounded
the outcomes. However, the evidence provided by the present
study, and other data in the literature, suggests that it would be
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ethical and desirable to conduct a larger multicentre randomized
prospective trial to definitively evaluate the outcome of a pancre-
atic resection with and without routine intra-peritoneal drainage.
Conclusion
Abandoning the practice of routine intraperitoneal drainage after
a pancreatic resection may not increase the overall incidence or
severity of severe post-operative complications but the spectrum
of complications may be altered. The benefits derived by patients
who avoid drains may be offset by a subset of patients who require
readmission and post-operative percutaneous drainage.
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